头孢他啶治疗儿童由假单胞菌属引起的严重尿路感染
Ceftazidime in the treatment of pediatric patients with severe urinary tract infections due to Pseudomonas spp.
作者信息
Rusconi F, Assael B M, Florioli A, Zaffaroni G
出版信息
Antimicrob Agents Chemother. 1984 Mar;25(3):395-7. doi: 10.1128/AAC.25.3.395.
Abstract
Fifteen pediatric patients with complicated urinary tract infections due to Pseudomonas spp. were treated for 10 to 18.5 days with ceftazidime administered intramuscularly twice daily. Urine sterilization during therapy was obtained in all patients. Three patients had relapses which were cured with a second course of ceftazidime. Minor liver damage, eosinophilia, and Candida superinfection developed in one patient each.
摘要
15例由假单胞菌属引起复杂性尿路感染的儿科患者接受了头孢他啶治疗，每日两次肌肉注射，疗程为10至18.5天。所有患者在治疗期间尿液均实现无菌。3例患者复发，经第二个疗程的头孢他啶治愈。分别有1例患者出现轻度肝损伤、嗜酸性粒细胞增多和念珠菌二重感染。
相似文献
1
Ceftazidime in the treatment of pediatric patients with severe urinary tract infections due to Pseudomonas spp.头孢他啶治疗儿童由假单胞菌属引起的严重尿路感染
Antimicrob Agents Chemother. 1984 Mar;25(3):395-7. doi: 10.1128/AAC.25.3.395.
2
Ceftazidime as a single agent in the treatment of severe Pseudomonas aeruginosa infections.头孢他啶单药治疗严重铜绿假单胞菌感染。
J Antimicrob Chemother. 1983 Jul;12 Suppl A:207-11. doi: 10.1093/jac/12.suppl_a.207.
3
Clinical pharmacology of ceftazidime in paediatrics.头孢他啶在儿科的临床药理学
J Antimicrob Chemother. 1983 Jul;12 Suppl A:341-6. doi: 10.1093/jac/12.suppl_a.341.
4
A random comparative trial of 0.25, 0.5 and 1.0 g ceftazidime twice daily in urinary tract infection.一项关于每日两次使用0.25克、0.5克和1.0克头孢他啶治疗尿路感染的随机对照试验。
J Antimicrob Chemother. 1983 Jul;12 Suppl A:53-7. doi: 10.1093/jac/12.suppl_a.53.
5
Ceftazidime in the treatment of urinary tract infection.头孢他啶治疗尿路感染。
Curr Med Res Opin. 1982;8(4):266-73. doi: 10.1185/03007998209109777.
6
A comparison of ceftazidime and tobramycin in the treatment of complicated urinary tract infections.头孢他啶与妥布霉素治疗复杂性尿路感染的比较。
J Antimicrob Chemother. 1983 Jul;12 Suppl A:47-52. doi: 10.1093/jac/12.suppl_a.47.
7
Evaluation of the usefulness of a novel injectable cephalosporin, E1040, and ceftazidime for management of complicated urinary tract infections caused by Pseudomonas aeruginosa and Proteus mirabilis by using the rat urolithiasis model.通过大鼠尿路结石模型评估新型注射用头孢菌素E1040和头孢他啶对铜绿假单胞菌和奇异变形杆菌所致复杂性尿路感染的治疗效果。
Antimicrob Agents Chemother. 1992 Jul;36(7):1580-3. doi: 10.1128/AAC.36.7.1580.
8
Ceftazidime in patients with severe Pseudomonas infections.
Int J Clin Pharmacol Ther Toxicol. 1986 Mar;24(3):159-64.
9
Ceftazidime therapy for serious infections.头孢他啶治疗严重感染。
J Antimicrob Chemother. 1983 Jul;12 Suppl A:115-21. doi: 10.1093/jac/12.suppl_a.115.
10
Clinical efficacy of ceftazidime. Treatment of serious infection due to multiresistant Pseudomonas and other gram-negative bacteria.头孢他啶的临床疗效。治疗多重耐药铜绿假单胞菌及其他革兰氏阴性菌引起的严重感染。
Arch Intern Med. 1984 Jan;144(1):57-62. doi: 10.1001/archinte.144.1.57.
引用本文的文献
1
Comparison of ceftazidime with cefamandole for therapy of community-acquired pneumonia.头孢他啶与头孢孟多治疗社区获得性肺炎的比较。
Antimicrob Agents Chemother. 1985 Jul;28(1):146-8. doi: 10.1128/AAC.28.1.146.
2
Ceftazidime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.头孢他啶。对其抗菌活性、药代动力学特性及治疗用途的综述。
Drugs. 1985 Feb;29(2):105-61. doi: 10.2165/00003495-198529020-00002.
3
[Ceftazidime in the treatment of pediatric infections--a review].[头孢他啶治疗小儿感染——综述]
Infection. 1987;15 Suppl 4:S202-8. doi: 10.1007/BF01645872.
4
Aztreonam in the treatment of severe urinary tract infections in pediatric patients.氨曲南治疗小儿重症尿路感染
Antimicrob Agents Chemother. 1986 Aug;30(2):310-4. doi: 10.1128/AAC.30.2.310.
本文引用的文献
1
THE LOCALIZATION AND TREATMENT OF URINARY TRACT INFECTIONS: THE ROLE OF BACTERICIDAL URINE LEVELS AS OPPOSED TO SERUM LEVELS.泌尿道感染的定位与治疗：杀菌尿液水平相对于血清水平的作用
Medicine (Baltimore). 1965 Jan;44:1-36. doi: 10.1097/00005792-196501000-00001.
2
Comparison of in vitro activities of eight beta-lactamase-stable cephalosporins against beta-lactamase-producing gram-negative bacilli.八种β-内酰胺酶稳定型头孢菌素对产β-内酰胺酶革兰氏阴性杆菌的体外活性比较
Antimicrob Agents Chemother. 1981 Mar;19(3):407-13. doi: 10.1128/AAC.19.3.407.
3
Antibacterial activity and beta-lactamase stability of ceftazidime, an aminothiazolyl cephalosporin potentially active against Pseudomonas aeruginosa.头孢他啶的抗菌活性及β-内酰胺酶稳定性，一种对铜绿假单胞菌可能具有活性的氨噻唑基头孢菌素。
Antimicrob Agents Chemother. 1982 Jan;21(1):11-8. doi: 10.1128/AAC.21.1.11.
4
Ceftazidime as a single agent in the treatment of severe Pseudomonas aeruginosa infections.头孢他啶单药治疗严重铜绿假单胞菌感染。
J Antimicrob Chemother. 1983 Jul;12 Suppl A:207-11. doi: 10.1093/jac/12.suppl_a.207.
5
Ceftazidime in treatment of acute pulmonary exacerbations in patients with cystic fibrosis.
J Pediatr. 1983 Aug;103(2):320-4. doi: 10.1016/s0022-3476(83)80377-1.
6
Ceftazidime--a new extended-spectrum cephalosporin.头孢他啶——一种新型广谱头孢菌素。
Lancet. 1982 May 22;1(8282):1152-6. doi: 10.1016/s0140-6736(82)92228-0.
7
Abnormal serum transaminase levels after parenteral ampicillin and carbenicillin administration.肠胃外给予氨苄西林和羧苄西林后血清转氨酶水平异常。
N Engl J Med. 1970 May 7;282(19):1081-2. doi: 10.1056/NEJM197005072821907.
8
Asymptomatic and symptomatic urinary tract infection in infancy.婴儿期无症状和有症状的尿路感染
Am J Dis Child. 1973 Jan;125(1):45-7. doi: 10.1001/archpedi.1973.04160010025006.
9
Pharmacokinetics and safety of cefamandole in infants and children.头孢孟多在婴幼儿及儿童中的药代动力学与安全性
Antimicrob Agents Chemother. 1978 Dec;14(6):838-41. doi: 10.1128/AAC.14.6.838.
Zotero 插件